`16529
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`GENENTECH, INC. and CITY OF HOPE,
`
`Plaintiffs,
`
`C.A. No. 18-cv-924-CFC
`
`v.
`
`AMGEN INC.,
`
`Defendant.
`
`
`
`
`
`
`
`
`STIPULATION AND [PROPOSED] ORDER REGARDING CLAIM CONSTRUCTION
`OF U.S. PATENT NOS. 6,627,196, 7,371,379, AND 10,160,811
`
`WHEREAS Plaintiffs Genentech, Inc. and City of Hope have sued Defendant Amgen Inc.
`
`for infringement of, among other things, U.S. Patent Nos. 6,627,196 (“the ’196 patent”),
`
`7,371,379 (“the ’379 patent”), and 10,160,811 (“the ’811 patent”);
`
`WHEREAS the parties initially identified the term “an initial dose” in claims 11 and 22
`
`of the ’196 patent, claims 11 and 21 of the ’379 patent, and claims 6 and 7 of the ’811 patent as a
`
`claim term for construction in this case;
`
`
`
`
`
`WHEREAS, in these circumstances, Plaintiffs believe there is no ripe claim construction
`
`dispute for the Court to resolve with respect to the term “an initial dose” in claims 11 and 22 of
`
`the ’196 patent, claims 11 and 21 of the ’379 patent, and claims 6 and 7 of the ’811 patent (which
`
`was briefed in the Revised Joint Claim Construction Brief (D.I. 121) at pages 3-33) as a claim
`
`term for construction in this case;
`
`NOW THEREFORE, subject to the approval of the Court, it is hereby stipulated and
`
`agreed by the Parties that, for purposes of this case, the term “an initial dose” in claims 11 and 22
`
`PUBLIC VERSION FILED:
`APRIL 24, 2019
`
`
`
`Case 1:18-cv-00924-CFC-SRF Document 151 Filed 04/24/19 Page 2 of 3 PageID #:
`16530
`
`of the ’196 patent, claims 11 and 21 of the ’379 patent, and claims 6 and 7 of the ’811 patent as a
`
`claim term for construction in this case shall mean “the first dose of the claimed antibody given
`
`to the patient as part of a treatment regimen.”
`
`
`
`
`
`
`
`
`
`
`
`MCCARTER & ENGLISH, LLP
`
`/s/ Daniel M. Silver
`Michael P. Kelly (#2295)
`Daniel M. Silver (#4758)
`Alexandra M. Joyce (#6423)
`Renaissance Centre
`405 North King Street, 8th Floor
`Wilmington, DE 19801
`(302) 984-6300
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`Of Counsel:
`
`William F. Lee
`Lisa J. Pirozzolo
`Emily R. Whelan
`Kevin S. Prussia
`Andrew J. Danford
`WILMER CUTLER PICKERING HALE AND DORR LLP
`60 State Street
`Boston, MA 02109
`(617) 526-6000
`william.lee@wilmerhale.com
`lisa.pirozzolo@wilmerhale.com
`emily.whelan@wilmerhale.com
`kevin.prussia@wilmerhale.com
`andrew.danford@wilmerhale.com
`
`SMITH KATZENSTEIN & JENKINS LLP
`
`/s/ Eve H. Ormerod
`Neal C. Belgam (#2721)
`Eve H. Ormerod (#5369)
`1000 West Street, Suite 1501
`Wilmington, DE 19801
`(302) 652-8400
`nbelgam@skjlaw.com
`eormerod@skjlaw.com
`
`Of Counsel:
`
`Michelle Rhyu
`Susan Krumplitsch
`Daniel Knauss
`COOLEY LLP
`3175 Hanover Street
`Palo Alto, CA 94304-1130
`(650) 843-5287
`skrumplitsch@cooley.com
`mrhyu@cooley.com
`dknauss@cooley.com
`
`Orion Armon
`COOLEY LLP
`380 Interlocken Crescent, Suite 900
`Broomfield, CO 80021-8023
`(720) 566-4119
`oarmon@cooley.com
`
` 2 -
`
`
`
`-
`
`
`Case 1:18-cv-00924-CFC-SRF Document 151 Filed 04/24/19 Page 3 of 3 PageID #:
`16531
`
`
`Robert J. Gunther Jr.
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`(212) 230-8800
`robert.gunther@wilmerhale.com
`
`Daralyn J. Durie
`Adam R. Brausa
`DURIE TANGRI LLP
`217 Leidesdorff St.
`San Francisco, CA 94111
`(415) 362-6666
`ddurie@durietangri.com
`abrausa@durietangri.com
`
`Attorneys for Plaintiffs Genentech, Inc. and
`City of Hope
`
`Dated: April 17, 2019
`
`
`Eamonn Gardner
`COOLEY LLP
`4401 Eastgate Mall
`San Diego, CA 92121-1909
`(858) 550-6086
`egardner@cooley.com
`
`Nancy Gettel
`Thomas Lavery, IV
`AMGEN INC.
`One Amgen Center Drive
`Thousand Oaks, CA 91320-1799
`(805) 447-1000
`ngettel@amgen.com
`tlavery@amgen.com
`
`Attorneys for Defendant Amgen Inc.
`
`
`
`
`
`
`
`
`
`
`
`
`
`SO ORDERED this ________ day of _______________________, 2019.
`
`_________________________________
` United States District Judge
`
` 3 -
`
`
`
`-
`